Drug profile · INN
ibuprofen
IBUPROFEN/DIPHENHYDRAMINE HYDROCHLORIDE WYETH
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
ibuprofen (IBUPROFEN/DIPHENHYDRAMINE HYDROCHLORIDE WYETH) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11806400
Injectable ibuprofen formulation
granted -
US 9931311
Treating critically ill patients with intravenous ibuprofen
granted -
US 9649284
Treating critically ill patients with intravenous ibuprofen
granted -
US 9295639
Treating critically ill patients with intravenous ibuprofen
granted -
US 9138404
Treating critically ill patients with intravenous ibuprofen
granted -
US 9114068
Treating patients with intravenous ibuprofen
granted -
US 9072710
Injectable ibuprofen formulation
granted -
US 9072661
Injectable ibuprofen formulation
granted
Frequently asked questions
What is ibuprofen?
ibuprofen (IBUPROFEN/DIPHENHYDRAMINE HYDROCHLORIDE WYETH) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ibuprofen?
IBUPROFEN/DIPHENHYDRAMINE HYDROCHLORIDE WYETH is a marketed brand name for ibuprofen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibuprofen?
ibuprofen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.